Quadrant Capital Group’s Research Frontiers REFR Stock Holding History

Quadrant Capital Group’s Portfolio REFR Stock Details REFR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,292	Closed	-$5K	–	2621
2021 Q2	$5K	Buy	+2,292	New	+$5.71K	﹤0.01%	1853

Other funds holding REFR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Quadrant Capital Group's REFR Position: Q3 2021 in Review

Quadrant Capital Group sold out of Research Frontiers (REFR) in Q3 2021, closing a stake of 2,292 shares — an estimated $5K sold.

Quadrant Capital Group first reported a position in REFR in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 32 funds tracked by Wall St. Rank hold REFR as of Q3 2021.

Quadrant Capital Group reported no remaining Research Frontiers position as of Q3 2021 after selling out during the quarter.
Quadrant Capital Group sold 2,292 Research Frontiers shares in Q3 2021, an estimated $5K.
Quadrant Capital Group first reported a position in Research Frontiers in Q2 2021 and held it in 1 quarter.
Quadrant Capital Group's Research Frontiers position peaked at $5K in Q2 2021.
32 funds tracked by Wall St. Rank held Research Frontiers as of Q3 2021.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.